INTRODUCTION
Leprosy is an ancient infectious disease caused by Mycobacterium leprae (M. leprae) that affects the skin and peripheral nerves. Although treatable, it remains as a major cause of disability and social stigma in many parts of the world, particularly in developing countries, with 210,758 new cases reported in 2015 (World Health Organization, 2016) . To understand the genetic basis of leprosy susceptibility, candidate gene-based association analysis and genome-wide linkage and association studies (GWASs) have been performed, and 21 common risk variants were discovered, showing the involvement of the innate and adaptive immune responses (Liu et al., 2012 (Liu et al., , 2013 (Liu et al., , 2015 Misch et al., 2010; Wang et al., 2016; Wong et al., 2010; Zhang et al., 2009 Zhang et al., , 2011 . However, these common risk variants are largely located within noncoding regions. Protein-coding variants, particularly low-frequency and rare ones, have not been investigated systematically, although these variants may probably be the causal ones in most cases (Bodmer and Bonilla, 2008; Fearnhead et al., 2005; Frazer et al., 2009) .
Here we performed a three-stage GWAS of protein-coding variants in leprosy. In the discovery stage, 40,491 coding variants were tested for single variant association in 1,648 leprosy patients and 2,318 healthy control subjects. We then validated and replicated our findings in four independent cohorts, totaling 5,400 leprosy patients and 12,080 healthy control subjects. In addition, we performed the biological and network analysis of seven genes identified in this study and 26 susceptibility genes implicated in the previous leprosy GWASs to provide more information on leprosy genetic pathogenesis.
RESULTS

Exome-wide discovery analysis
In the discovery stage (stage 1), we successfully genotyped 273,028 variants in 1,670 leprosy patients and 2,321 control individuals. Principal component analysis confirmed the Chinese ancestry of all participant samples, and a good genetic match between the patients and control subjects was observed (see Supplementary Figures S1, S2 online). After a series of sample and variant quality control filtering, 74,764 polymorphic coding variants were retained for association test. According to the result of the power analysis by Genetic Power Calculator (available at_http://zzz.bwh.harvard.edu/ gpc/cc2.html), the sample size of our discovery analysis was underpowered for detecting single variants with minor allele frequency (MAF) (in all samples) less than 0.1%, hence only 40,491 coding variants with MAF (in all samples) greater than 0.1% (38,068 nonsynonymous and 2,423 synonymous ones) were tested for single variant association in 1,648 leprosy patients and 2,318 healthy control subjects by GMMAT (Breslow and Clayton, 1993; Chen et al., 2016) software.
As expected, the exome-wide analysis showed strong and extensive associations within the major histocompatibility complex region (Figures 1, 2a ). After removing all the variants within the major histocompatibility complex region, the quantile-quantile plot of the remaining single nucleotide polymorphisms (SNPs) showed a good fit with the expected null distribution (Figure 2b ), indicating a minimal inflation of exome-wide association results due to population stratification (l GC ¼ 0.99). Additional quantile-quantile plots of SNP sets with different MAF thresholds (>0.5%, >1%, and >5%) also showed consistent indication of minimal inflation (see Supplementary Figure S3 online).
The strongest association was obtained at rs3200405 (P ¼ 3.46 Â 10 À40 , odds ratio [OR] ¼ 2.15) within HLA-DRB5, which is correlated to the previously reported GWAS SNP rs9271100 and HLA allele HLA-DRB1*15:01 (Liu et al., 2015; Rani et al., 1993; Wang et al., 2016) Supplementary Table S1 online). Five coding variants (four common and one low frequency) with suggestive association (P < 1.0 Â 10 e3 ) were also found within the previously identified GWAS loci (Liu et al., 2012 (Liu et al., , 2013 (Liu et al., , 2015 Wang et al., 2016; Zhang et al., 2009 Zhang et al., , 2011 . All four common coding variants were in high linkage disequilibrium with the previously reported SNPs, and only the low-frequency variant (rs76418789 in IL23R) showed independent association (see Supplementary Table S1 ). In addition, a moderate deviation of the quantile-quantile plot from the expected null distribution was observed at the tail of distribution (after removing all the SNPs within the major histocompatibility complex region), indicating the existence of associations (Figure 2, Supplementary Figure S3 ). There were 38 coding variants in, to our knowledge, previously unreported genes with suggestive association significance (P < 1.0 Â 10 e3 ).
To further investigate the role of low-frequency and rare coding variants, we carried out gene-based tests using SKAT-O (Lee et al., 2012b) and burden test methods (Lee et al., 2012a) . However, both SKAT-O and burden test analyses failed to provide indication of true genetic association beyond expectation by chance (see Supplementary  Figures S4 , S5 online).
Validation analysis
A total of 39 independent coding variants were genotyped in an additional 3,169 leprosy patients and 9,814 healthy control subjects from the northern region of China (stage 2). Of the 34 successfully genotyped variants, 15 were found to show consistent associations between the discovery and validation samples (P < 0.05 in the validation samples and OR in the same direction as in the discovery stage), and six reached exome-wide significance (P < 0.05/40,491 ¼ 1.23 Â 10 À6 based on Bonferroni correction, which is a conservative way to control for false positives as multiple tests are performed) (Duggal et al., 2008; Gibson, 2012) in the combined discovery and validation samples without evidence of heterogeneity: rs145562243 in NCKIPSD (P ¼ 1.44 Â 10 e8 , OR ¼ 4.35), rs149308743 in CARD9 (P ¼ 4.99 Â 10 e10 , OR ¼ 4.75), rs76418789 in IL23R (P ¼ 6.28 Â 10 e9 , OR ¼ 1.37), rs146466242 in FLG (P ¼ 1.44 Â 10 e10 , OR ¼ 1.45), rs780668 in SLC29A3 (P ¼ 2.89 Â 10 e7 , OR ¼ 1.14), and rs181206 in IL27 (P ¼ 5.92 Â 10 e7 , OR ¼ 0.83) ( Table 1 , Supplementary Table S2 online). In addition, two coding variants, rs55882956 in TYK2 (P ¼ 2.75 Â 10 e5 , OR ¼ 1.29) and rs75746803 in USP49 (P ¼ 3.45 Â 10 e6 , OR ¼ 1.28) showed consistent associations between the discovery and validation samples but were barely below the exomewide significance in the combined samples (Table 1 , Supplementary Table S2 ).
Replication analysis
Eight nonsynonymous coding variants were further selected for replication analysis using the following criteria: (i) showing consistent association in the validation stage at P-value less than 0.005 and (ii) had a P-value less than 5Â 10 e5 in the meta-analysis of the discovery and validation samples. The replication study (stage 3) was performed by using additional independent samples from three southern regions of China, totaling 2,231 leprosy patients and 2,266 healthy control subjects (see Supplementary Table S3 online). Five of the eight variants obtained significant associations in the replication samples alone (rs76418789 in IL23R, P ¼ 4.35 Â 10 e3 ; rs146466242 in FLG, P ¼ 6.58 Â 10 e3 ; rs55882956 in TYK2, P ¼ 1.15 Â 10 e2 ; rs780668 in SLC29A3, P ¼ 2.05 Â 10 e3 ; rs145562243 in NCKIPSD, P ¼ 3.16 Â 10 e2 ). Out of the three nonsignificant variants, one (rs149308743 in CARD9, P ¼ 8.69 Â 10 e1 ) is very rare, another (rs181206 in IL27, P ¼ 6.09 Â 10 e2 ) is on the borderline, and the third variant (rs75746803 in USP49, P ¼ 3.27 Â 10 e1 ) showed inconsistent genetic effect across the three replication samples.
We then performed the meta-analysis of all the samples from the three stages, consisting of a total of 7,048 patients and 14,398 control subjects, using the Fisher combination method for rare variants and a fixed-effect model for the others. Seven (two rare, three low-frequency, and two common) coding variants showed consistent associations without significant evidence of heterogeneity and reached the exome-wide significance in the combined samples (Table 1) . rs75746803 in USP49 on chromosome locus 6p21.1 remained barely below exome-wide significance (MAF ¼ 4.8%, P ¼ 3.57 Â 10 e6 , OR ¼ 1.25) (Table 1, Figure 1 , Supplementary Table S2 , and Supplementary Figure S6 online).
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Conditional and haplotype analyses
To verify whether the low-frequency coding variant rs76418789 is independent of the previously reported GWAS SNP rs3762318 (Zhang et al., 2011) within IL23R, we performed conditional and haplotype analyses of the two variants using the overlapping samples between the current study and the datasets in the previously published GWASs (Liu et al., 2015; Zhang et al., 2009 ) (including 3,019 patients and 5,767 control subjects of northern Chinese Han ethnicity). Conditioning on rs3762318 had a minimal impact on the association at rs76418789 (P conditional ¼ 9.06 Â 10 À4 , OR conditional ¼ 1.26 vs. P ¼ 1.04 Â 10 e4 , OR ¼ 1.30) (see Supplementary Table S5 online). Consistently, the haplotype analysis showed that the AA haplotype (i.e., carrying the two risk alleles of the two variants) confers significantly higher risk than the AG haplotype (i.e., carrying only the risk allele of rs3762318), confirming further the independent risk effects of these two SNPs within IL23R (see Supplementary Table S6 online). We also probed the association evidence for the two common coding variants (rs780668 in SLC29A3 and rs181206 in IL27) in our previously reported GWAS dataset (1,548 patients and 6,512 control subjects) (Liu et al., 2015) and found that both rs780668 and rs181206 were filtered out in the imputation stage of our previous GWAS because of low imputation information score. All the other low-frequency and rare coding variants identified in this study are either outside the linkage disequilibrium blocks of or independent from the previously reported GWAS SNPs.
Risk explained by identified variants
Commutatively, the seven coding variants could explain 1.20% of risk, which is much lower than the 17.01% of risk explained by the 20 GWAS loci (22 independent GWAS SNPs). Of the seven coding risk variants, only two showed strong genetic effect (OR > 4), but they are extremely rare (MAF in control subjects < 0.1%), and as a result, their contribution to the overall risk of leprosy is very small. The other five variants all showed moderate genetic effect. Together, 18.21% of leprosy risk can be explained by all 29 genetic risk variants that have been discovered so far (see Supplementary Table S7 online).
Biological and network analysis
All seven coding risk variants discovered in this study are nonsynonymous and were found to be deleterious by either SIFT tool (available from http://sift.bii.a-star.edu.sg), PolyPhen-2 tool (available from http://genetics.bwh.harvard. edu/pph2/bgi.shtml), or protein structural analysis (see Supplementary Table S8 and Supplementary Figures S7eS10  online) . Except for rs76418789 within the known leprosy gene IL23R (Zhang et al., 2011) , all coding risk variants are within genes that have not been reported before to our knowledge (Table 1 and Figure 1) , justifying the value of investigating exome-wide coding variants. We performed gene ontology (GO) enrichment analysis of seven genes identified in this study and of those seven genes together with 26 susceptibility genes implicated in the previous leprosy GWASs. The analysis showed that the regulation of immune response (GO: 0050776, P ¼ 5.00 Â 10 e6 ) and the immune response (GO: 0006955, P ¼ 3.10 Â 10 e14 ) are the most enriched GO term for the two gene sets, respectively (Liu et al., 2012 (Liu et al., , 2013 (Liu et al., , 2015 Wang et al., 2016; Zhang et al., 2009 Zhang et al., , 2011 ) (see Supplementary Table S9 and Supplementary Figure S11 online) . According to the GO hierarchy, the GO: 0050776 is annotated as the "Regulate" of the GO: 0006955, indicating that the leprosy genes discovered in this are closely connected (in terms of molecular function) with the ones implicated by the previous GWASs.
An integrated gene network analysis of all 33 susceptibility genes (identified by previous GWASs and these analyses) using GeneMANIA (Mostafavi et al., 2008) in Cytoscape tool Indicates results from fixed-effects meta-analysis. 4 For rare variants in the three replications, F_A is count for A1A1/A1A2/A2A2 in patients; F_U is count for A1A1/A1A2/A2A2 in control subjects. Because of the large deviations of the estimated OR in the small samples, we reported only their association P-values, which were calculated by Fisher exact test.
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Genome-Wide Analysis of Protein-Coding Variants in Leprosy (http://www.cytoscape.org/) was performed. The analysis showed a highly interactive gene network where all the significant subnetworks are found to be associated with specific functions and components of immunity (see Supplementary  Figure S12 online). For example, a group of subnetworks that contains susceptibility genes HLA-DRB1, HLA-DQB1, NOD2, IL27, IL23R, and IL12B plays an important role in the regulation of T-cell activation (P ¼ 7.09 Â 10 e9 ), adaptive immune response (P ¼ 7.68 Â 10 e8 ) and IFN-g production (P ¼ 2.92 Â 10 e6 ) (see Supplementary Table S10 online and Supplementary Figure S12 ). Another cluster of subnetworks involving BCL10, CARD9, RIPK2, NOD2, SOCS1, IL12B, PPARG, CTSB, and TYK2 are related to the regulation of innate immune response (P ¼ 7.09 Â 10 e9 ) and positive regulation of NF-kB transcription factor activity (P ¼ 8.95 Â 10 e6 ) (see Supplementary Table S10 and Supplementary Figure S12 ).
DISCUSSION
By carrying out a three-stage exome-wide association study of protein-coding variants in the Chinese population, we have discovered seven nonsynonymous risk variants for leprosy, including five low-frequency and rare ones. These coding risk variants showed six, to our knowledge previously unreported, disease susceptibility genes for leprosy. The individual genetic effects (ORs) of low-frequency and rare coding risk variants are stronger than common variants (identified by GWAS), although their contributions to risk are, individually or cumulatively, weaker (because of their low frequency) than the common ones, which did not support the hypothesis that protein-coding risk variants have strong genetic effects, and the "missing of heritability" of complex diseases (failed to be explained by GWAS loci) can be explained by the strong genetic effects of protein-coding variants. Through the integrated gene network analysis of leprosy susceptibility genes discovered by the current protein-coding variant study and previous GWASs, we have also shown the involvement of both innate and adaptive immunity in leprosy. In particular, our study has highlighted the important roles of several specific functional components of immunity, such as the regulation of T activation, IFN-g production, NF-kB transcription factor activity, and innate immune response. The highly integrated gene network implicated by leprosy disease genes also contains additional genes (see Supplementary Figure S12 ) whose involvements in leprosy have not been shown. These genes are strong candidates for future genetic study of leprosy.
FLG was not a part of the gene network, coinciding with non-immunity functionality of this gene shown by our literature review. The FLG gene encoded profilaggrin and filaggrin, which play a pivotal role in skin barrier function by affecting formed stratum corneum and water binding (Sandilands et al., 2009; Scott and Harding, 1986) . It has long been believed that the upper respiratory tract is the primary route of infection for M. leprae, although few case reports of skin injury-induced leprosy lesions suggested the possibility of infection through skin (Abraham et al., 1998; Ghorpade, 2002) . Together with the finding that filaggrin is not expressed in the normal upper airway (De Benedetto et al., 2008) , our discovery of FLG as a disease susceptibility gene for leprosy provides strong genetic evidence that impaired skin barrier plays an important role in leprosy, and direct contact through skin might be an important route of infection for M. leprae.
Literature review also showed that NCKIPSD is not related to the immunity, although it has been included in the gene network. The protein of NCKIPSD belongs to the NCK family of adaptor proteins, major regulators of act in the cytoskeleton. It is a part of FCG receptor-dependent phagocytosis pathway and is implicated in many functional processes, such as assembly and maintenance of sarcomeres and stress fiber formation (Lim et al., 2001; Satoh and Tominaga, 2001) . The rare variant rs145562243 (p.R176Q) was located in the proline-rich region (PRD) of the NCKIPSD N-terminus, whose overexpression was found to be related to abnormalities in vesicle formation and trafficking, leading to the defective endocytosis of FCG receptor (Oh et al., 2013) . Together with the identification of RAB32 (Zhang et al., 2011) , which has been shown to be involved in autophagy and phagocytotic digestion of bacteria (Hirota and Tanaka, 2009; Seto et al., 2011; Spano and Galan, 2012) , as well as LRRK2 (Zhang et al., 2009) as an interacting partner of RAB32 (Waschbusch et al., 2014) and related to cell death due to autophagic dysfunction and mitochondrial damage (Alegre-Abarrategui et al., 2009; Plowey et al., 2008) , the discovery of NCKIPSD highlights the potential involvement of endocytosis/phagocytosis/autophagy in host defense against M. leprae infection.
We acknowledge that the results from the Gene Mania analysis or GO term enrichment analysis are broad in terms of functional inference, and future integrated analysis with other types of data, for example, gene expression profiles or epigenetic data, may provide more specific functional impacts of the reported variants.
MATERIALS AND METHODS
Study subjects
We performed a three-stage case-control analysis for this study. Stage 1 and stage 2 included 16,974 individuals from the northern region of China. Stage 3 included 2,231 leprosy patients and 2,266 healthy control subjects from southern China. All patients and healthy control subjects with written informed consent were recruited as previously described (Zhang et al., 2009 ). All individuals were of Chinese descent, and the clinical information of samples is summarized in Supplementary Table S3 .
This study was approved by the institutional review board committee at the Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences.
Genotyping and quality control in the discovery stage
We carried out this study using Illumina Infinium Human Exome Bead Chip (version 1.0) array (Illumina, San Diego, CA). SNPs went through the following quality control filters: call rate greater than 99%, MAF in all samples greater than 0.1%, and Hardy-Weinberg equilibrium P-value in control subjects greater than 1.0 Â 10 À8 . We also excluded SNPs located in non-autosomal chromosomes and noncoding regions. A total of 40,491 genotyped SNPs were used for association analysis in the discovery stage.
The samples with call rate of less than 98%, one of related pairs (first-, second-or third-degree familial relationships) with lower call rate (seven), and population outliers based on the principal component analysis method (16 patients and two control subjects) were excluded. Overall, 1,648 patients and 2,318 control subjects passed the sample quality control filters and were used in the discovery analysis.
Statistical analysis
In the discovery stage, we tested associations between phenotypes and single-variant genotypes using GMMAT_v0.7 (Breslow and Clayton, 1993; Chen et al., 2016) . In the validation and replication stages, we used a logistic regression model for those SNPs with MAF greater than 1% and Fisher exact test for those SNPs with MAF less than 1%. The meta-analysis was performed using a fixed-effect model. We declared a single variant-trait association significant if the nominal P-value was less than 1.23 Â10 e6 (0.05/40491). Assessment of OR heterogeneity across independent samples was carried out by evaluating the P-values from Cochran Q statistics, and heterogeneity P-values less than 0.05 were considered significant.
Genotyping analysis and quality control in the validation and replication studies SNP genotyping for the validation and replication stages were conducted at the Shandong Provincial Key Laboratory for Dermatovenereology using the Sequenom MassARRAY system, OpenArray custom genotyping assays on QuantStudio 12K Flex Real-Time PCR System (Applied Biosystems, Foster City, CA) and TaqMan custom genotyping assays on a 7900 HT Fast Real-Time PCR System (Applied Biosystems) according to the manufacturers' instructions. The following quality control filters were adopted: variants with undetermined clusters or variants with call rate less than 90%, variants with significant deviation from Hardy-Weinberg equilibrium in control samples (Hardy-Weinberg equilibrium, P < 1 Â 10 À3 ), and samples with call rate less than 95% were excluded.
Biological and network analysis
GO enrichment analysis.
GO enrichment analysis was performed with seven identified genes set from the current study and 33-gene set, including seven genes from the current study and 26 reported genes from previous GWASs (Liu et al., 2012 (Liu et al., , 2013 (Liu et al., , 2015 Wang et al., 2016; Zhang et al., 2009 Zhang et al., , 2011 , respectively. GO enrichment was implemented by TopGO (Alexa et al., 2006) , an R package, which calculates GO enrichment P-values for a given gene list. The 30 most significant GO terms are listed in the Supplementary Table S9 .
Integrated network enrichment.
GeneMANIA (Multiple Association Network Integration Algorithm) (Mostafavi et al., 2008) in Cytoscape was applied to the 33-gene set to carry out the integrated gene network analysis (see Supplementary Figure S12 ).
More detailed information on the study subjects, genotyping, quality control, variant selection, statistical analysis, and biological and network analyses is provided in the Supplementary Materials online.
